Literature DB >> 18722474

Detection and differentiation of human papillomavirus genotypes HPV-6 and HPV-11 by FRET-based real-time PCR.

Bostjan J Kocjan1, Katja Seme, Mario Poljak.   

Abstract

A real-time PCR (RT-PCR) assay was developed based on fluorescence resonance energy transfer (FRET) hybridization probe technology, allowing very sensitive and specific detection of HPV-6 and HPV-11, reliable differentiation of HPV-6 and HPV-11, as well as prototypic and non-prototypic HPV-6 genomic variants, in a single PCR reaction. The primers and probe were designed on the basis of multiple alignments of 74 HPV-6 E2 gene sequences and 20 HPV-11 E2 gene sequences. Testing on defined plasmid standards showed that the RT-PCR allowed simple and reliable identification of HPV-6 and HPV-11 using type specific amplification followed by probe-specific post-amplification dissociation analysis. Sensitivity, assessed by probit analysis at a 95% detection level, was 42.9, 43.4, and 25.3 DNA copies per assay for prototypic and non-prototypic HPV-6 variants and HPV-11, respectively. The results obtained by the developed assay on 51 HPV DNA-negative samples and 149 HPV DNA-positive samples, including 81 HPV-6 positive samples (19 prototypic and 62 non-prototypic HPV-6 variants), 28 HPV-11 positive samples, 10 samples of HPV-44 and HPV-74 (the closest relatives of HPV-6 and HPV-11) and 30 samples of 15 other important alpha HPV, showed complete agreement with those obtained with the INNO-LiPA human papillomavirus (HPV) Genotyping Assay and HPV-6 E2 and E6 gene sequencing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722474     DOI: 10.1016/j.jviromet.2008.07.014

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

Review 1.  Validation of laboratory-developed molecular assays for infectious diseases.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis.

Authors:  Irena Hočevar-Boltežar; Mojca Matičič; Maja Sereg-Bahar; Nina Gale; Mario Poljak; Boštjan Kocjan; Miha Zargi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-26       Impact factor: 2.503

3.  Human papillomavirus genotype specificity of hybrid capture 2 low-risk probe cocktail.

Authors:  Mario Poljak; Bostjan J Kocjan; Anja Kovanda; Maja M Lunar; Snjezana Zidovec Lepej; Ana Planinic; Katja Seme; Adriana Vince
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

4.  Clinical, Histopathological, and Virological Evaluation of 203 Patients With a Clinical Diagnosis of Molluscum Contagiosum.

Authors:  Katarina Trčko; Lea Hošnjak; Blanka Kušar; Tomaž Mark Zorec; Boštjan J Kocjan; Miljenko Križmarić; Katja Seme; Jovan Miljković; Boštjan Luzar; Mario Poljak
Journal:  Open Forum Infect Dis       Date:  2018-11-12       Impact factor: 3.835

5.  Human Papillomavirus Subtype 16 and the Pathologic Characteristics of Laryngeal Cancer.

Authors:  Mohammed Abdel Motaal Gomaa; Khalid Elsayed El Gindy; Usama Galal Abdel Nabi; Haitham M Mohammed; Nisreen A Abdel Twab; Rehab Mahmoud; Khalid M Mohiy
Journal:  OTO Open       Date:  2017-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.